Selecting and Managing CROs in Emerging Markets: How to Prepare Your Company for Global Growth in the Biopharmaceutical Space

Is your company preparing for international expansion? Whether you’re in the middle of a 10-year plan or just beginning to tackle the mountain of regulatory information required for bioprocessing operations in a new country, the Selecting and Managing CROs course is an excellent step to take that will set you on the path to success.

As the U.S. market for biopharmaceuticals matures and stabilizes, investors are looking to emerging markets in Asia and South America as potential locations for growth in both sales and manufacturing sites. CROs are emerging in these countries that provide world-class services, but among a host of choices, it may be difficult to know how to choose the right partner for your pharmaceutical company. In the Selecting and Managing CROs course, you will not only learn the beginning-to-end process of partnering with a Contract Research Organization but will gain an opportunity to network with representatives from this industry, as the course is open to both pharma professionals and CRO administrators and management.

In particular, the Chinese government’s Made in China initiative, with its 2025 deadline, is spotlighting the pharmaceutical industry, and savvy companies stateside will be wise to create partnerships with CROs that can receive government benefits. The establishment of a multi-national foothold in the country may also be a wise investment, as the global need for biopharmaceuticals and the expanding demand for these products is such that the current political protectionism in the U.S. may be short-sighted when it comes to expanding trade and investorship in the volatile biotech market.

Evaluating the degree to which your biopharmaceutical manufacturing will rely on CROs is an important and time-consuming decision, which is why our two-day course focuses in detail on deciding how much of the workload you should outsource, and what types of research and development activity you can hand off. Considering the growth in the upstream biopharmaceutical manufacturing process market in the U.S., for example, finding a CRO that can handle these large-volume development tasks will likely be essential for any biotech company focused on innovation.

To learn more about our course offerings, click here.